MedicineNet.com
About Us | Privacy Policy | Site Map
November 21, 2009
MedicineNet home Picture Slideshows Diseases and conditions Symptoms and signs Procedures and tests Medications Health and Living Picture Image Collection MedTerms medical dictionary
Font Size
A
A
A


Medications and Drugs

GENERIC NAME: olsalazine

BRAND NAME: Dipentum

DRUG CLASS AND MECHANISM: Olsalazine is a derivative of salicylic acid. Inactive by itself, it is converted by the bacteria in the colon to mesalamine. Mesalamine works as an anti-inflammatory agent in treating inflammatory diseases of the intestines. Its benefit is believed to be due to a local effect from within the bowel and, therefore, following oral administration very little (less than 10%) is absorbed. Mesalamine is thought to be the active component of sulfasalazine (Azulfidine). Olsalazine was approved by the FDA in July, 1990.

PRESCRIPTION: yes

GENERIC AVAILABLE: no

PREPARATIONS: Capsules (beige-orange) containing 250mg.

STORAGE: The capsules should be kept at room temperature, 15-30°C (59-86°F).

PRESCRIBED FOR: Olsalazine is used for the treatment of mild to moderately severe ulcerative colitis.

DOSING: Olsalazine is usually administered at a dose of 500mg (two capsules) twice daily. It is taken with meals.

DRUG INTERACTIONS: There are no known drug interactions with olsalazine.

PREGNANCY: It is not known whether olsalazine crosses the placenta to the fetus.

NURSING MOTHERS: It is not known whether olsalazine is secreted into breast milk.

SIDE EFFECTS: Gastrointestinal disturbances commonly occur in persons who take olsalazine. Diarrhea occurs in about 1 of every 6 persons who take it; about one in 20 need to discontinue therapy because the diarrhea is severe. Abdominal pain or cramps occur in 1 in 10 persons, and nausea or vomiting occurs in 1 in 20. Other side effects, including dizziness, depression, and headache, occur less frequently than gastrointestinal effects during therapy. Rashes occurs in 2.3% of persons and joint pain in 4%.

Reference: FDA Prescribing Information


Last Editorial Review: 12/31/1997




Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Printer-Friendly Format  |  Email to a Friend


Suggested Reading by Our Doctors
MedicineNet Doctors
  • Drug Interactions - Learn about potential drug interactions you may be exposed to. Drug interactions can occur with prescription drugs, OTC medication, vitamins, herbs, and supplements.
  • Crohn's Disease - Learn about Crohn's Disease and the causes, symptoms (including abdominal pain, diarrhea, weight loss, fever, rectal bleeding, and more) and treatment of this chronic inflammatory disease of the intestines.
  • sulfasalazine, Azulfidine - Information on the medication sulfasalazine (Azulfidine), a drug used for the treatment of ulcerative colitis, Crohn's disease, rheumatoid arthritis, or ankylosing spondylitis.

Latest Medical News


Back to Medications Index


Women's Health

Find out what women really need.


Are you Depressed? Take the Quiz

Your Guide to Symptoms & Signs: Pinpoint Your Pain



Related Drugs - WebMD Health Network

olsalazine, Dipentum

What is Crohn's disease?

Crohn's disease is a chronic inflammatory disease of the intestines. It primarily causes ulcerations (breaks in the lining) of the small and large intestines, but can affect the digestive system anywhere from the mouth to the anus. It is named after the physician who described the disease in 1932. It also is called granulomatous enteritis or colitis, regional enteritis, ileitis, or terminal ileitis.

Crohn's disease is related closely to another chronic inflammatory condition that involves only the colon called ulcerative colitis. Together, Crohn's disease and ulcerative colitis are frequently referred to as inflammatory bowel disease (IBD). Ulcerative colitis and Crohn's disease have no medical cure. Once the diseases begin, they tend to fluctuate between periods of inactivity (remission) and activity (relapse). They affect approximately 500,000 to two million people in the United States. Men and women are equally affected. IBD m...

Read the Crohn's Disease article »










Health categories:

Slideshows | Diseases & Conditions | Symptoms & Signs | Procedures & Tests | Medications | Health & Living | News & Views | Medical Dictionary

Popular health centers:

Allergies | Arthritis | Cancer | Diabetes | Digestion | Healthy Kids | Heart | Men's Health | Mental Health | Women's Health | More...

Publications:

ePublications (PDFs) | XML News via RSS | Audio Podcasts | Email Newsletters

MedicineNet.com:

About Us | Privacy Policy | Site Map | WebMD® | Medscape® | eMedicine® | eMedicineHealth® | RxList®

This website is certified by Health On the Net Foundation. Click to verify. This site complies to the HONcode standard for trustworthy health information:
verify here.

©1996-2009 MedicineNet, Inc. All rights reserved. Notices and Legal Disclaimer.
MedicineNet does not provide medical advice, diagnosis or treatment. See additional information.